Related Experiment Video

Updated: Apr 10, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

140

Therapeutic Potential of Targeting PAK Signaling

William Senapedis1, Marsha Crochiere, Erkan Baloglu

  • 1Karyopharm Therapeutics, Inc. Address: 85 Wells Avenue, Newton, Massachusetts, USA, 02459. william.senapedis@gmail.com.

Anti-Cancer Agents in Medicinal Chemistry
|June 18, 2015
PubMed

Insights

Targeting p21-Activated Kinases (PAK) shows promise for cancer treatment. PAK proteins, crucial for cell adhesion and migration, are elevated in many cancers and link Ras and β-catenin pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • p21-Activated Kinases (PAK1-6) are increasingly recognized as therapeutic targets in the biotech industry for cancer treatment.
  • PAK proteins regulate cell adhesion and migration, acting as downstream effectors of Ras signaling.
  • Elevated PAK expression is observed in various cancers, including pancreatic, colon, breast, and lung tumors, and drives disease progression, particularly in Ras-driven cancers.

Purpose of the Study:

  • To explore the therapeutic potential of targeting PAK proteins for cancer treatment.
  • To investigate the role of PAK proteins in linking Ras and β-catenin signaling pathways in cancer.

Main Methods:

  • Review of pre-clinical data on PAK inhibitors, including PF-3758309.
  • Analysis of PAK protein expression and function in various cancer types.
  • Examination of PAK substrates, such as β-catenin, and their role in cancer.

Main Results:

  • Multiple ATP-competitive PAK inhibitors are in pre-clinical development, with one compound (PF-3758309) reaching human trials.
  • Aberrant PAK activity, often due to gene amplification or transcriptional modifications rather than mutations, affects numerous substrates.
  • PAK proteins interact with both Ras and β-catenin signaling pathways, highlighting their central role in cancer.

Conclusions:

  • Therapeutic targeting of PAK proteins represents a promising strategy for a broad spectrum of oncological malignancies.
  • Understanding the interplay between PAK, Ras, and β-catenin signaling is crucial for developing effective cancer therapies.
  • Further development of PAK inhibitors could offer new treatment options for patients with various solid tumors.

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.8K
Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

15.9K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.6K